Team Member

Biography

Sai Krishna Gudi is a second-year Ph.D. student at the College of Pharmacy, University of Manitoba, where his current research looks at the utilization, effectiveness, and safety of direct-acting antivirals (DAAs) for Hepatitis-C in Manitoba. His education background includes a B.Sc (Pharm) and a PharmD degree from India, also an M.Sc (Pharm) from the University of Manitoba, Canada. He is a budding researcher in Pharmacoepidemiology & Outcomes Research, where he has authored around 22 papers published in reputed international journals. He has received various scholarships and awards for his academic excellence and scientific work throughout his educational journey. His primary research interest includes studying medication use and its long-term effects in large populations; comparative effectiveness & medication-safety research; optimizing irrational drug-use & medication appropriateness (over-treatment), particularly among older adults; knowledge translation through evidence-based practice; pharmaceutical policy & health-services research; confounding & bias analysis; and systematic reviews, meta-analysis & network meta-analysis methods